GAM Holding’s Envoy Medical COCH Stock Holding History

GAM Holding’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,600	Closed	-$397K	–	259
2022 Q1	$397K	Hold	40,600	–	–	0.02%	238
2021 Q4	$396K	Buy	+40,600	New	+$396K	0.02%	252

Other funds holding COCH

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

DAM

DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GAM Holding's COCH Position: Q2 2022 in Review

GAM Holding sold out of Envoy Medical (COCH) in Q2 2022, closing a stake of 40,600 shares — an estimated $397K sold.

GAM Holding first reported a position in COCH in Q4 2021 and held it in 2 quarters. The position peaked at $397K in Q1 2022. 89 funds tracked by Wall St. Rank hold COCH as of Q2 2022.

GAM Holding reported no remaining Envoy Medical position as of Q2 2022 after selling out during the quarter.
GAM Holding sold 40,600 Envoy Medical shares in Q2 2022, an estimated $397K.
GAM Holding first reported a position in Envoy Medical in Q4 2021 and held it in 2 quarters.
GAM Holding's Envoy Medical position peaked at $397K in Q1 2022.
89 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2022.

Based on GAM Holding's 13F filing for Q2 2022, filed 21 Jul 2022.